Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1440.30
2.95 (0.21%)
< Home < Back

Cipla - Quaterly Results

Date: 10-05-2024
The revenue for the March 2024 quarter is pegged at Rs. 40366.60 millions, about 13.20% up against Rs. 35658.80 millions recorded during the year-ago period.The Total revenue for the quarter ended March 2024 of  Rs. 9820.30  millions  grew by 238.27% from Rs. 2903.10 millions.OP of the company witnessed a marginal growth to 13665.00 millions from 8312.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 40366.60 35658.80 13.20 165743.40 143453.40 15.54 165743.40 143453.40 15.54
Other Income 5386.10 1197.10 349.93 10706.60 4567.90 134.39 10706.60 4567.90 134.39
PBIDT 13665.00 8312.00 64.40 55548.10 38096.80 45.81 55548.10 38096.80 45.81
Interest 54.50 92.70 -41.21 202.50 222.70 -9.07 202.50 222.70 -9.07
PBDT 13610.50 6360.30 113.99 55345.60 36015.10 53.67 55345.60 36015.10 53.67
Depreciation 1368.10 1615.80 -15.33 5875.90 5959.10 -1.40 5875.90 5959.10 -1.40
PBT 12242.40 4744.50 158.03 49469.70 30056.00 64.59 49469.70 30056.00 64.59
TAX 2422.10 1841.40 31.54 12327.80 8615.40 43.09 12327.80 8615.40 43.09
Deferred Tax 20.30 -385.80 -105.26 60.90 -400.90 -115.19 60.90 -400.90 -115.19
PAT 9820.30 2903.10 238.27 37141.90 21440.60 73.23 37141.90 21440.60 73.23
Equity 1614.70 1614.30 0.02 1614.70 1614.30 0.02 1614.70 1614.30 0.02
PBIDTM(%) 33.85 23.31 45.23 33.51 26.56 26.20 33.51 26.56 26.20